Based on experience in obtaining clinical trial approvals from the Ministry of Food and Drug Safety for various intractable diseases—including stroke, obesity, cancer cachexia, and muscular dystrophy—we provide regulatory consulting for biotechnology, pharmaceutical, and food technologies to support their practical application.

We also support business development opportunities for R&D-driven companies with proprietary biotechnologies and products but limited global business development capabilities, as well as for technology transfer offices (TLOs), research institutes, hospitals, schools and universities seeking partners for licensing and continued development of early-stage assets.